The PE Ratio as of July 2024 (TTM) for Century Therapeutics, Inc. (IPSC) is -1.13

According to Century Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.13. This represents a change of -22.39% compared to the average of -1.46 of the last 4 quarters.

Century Therapeutics, Inc. (IPSC) Historical PE Ratio (quarterly & annually)

How has IPSC PE Ratio performed in the past?

The mean historical PE Ratio of Century Therapeutics, Inc. over the last ten years is -8.16. The current -1.13 PE Ratio has changed 1.28% with respect to the historical average. Over the past ten years (40 quarters), IPSC's PE Ratio was at its highest in in the September 2023 quarter at -0.91. The PE Ratio was at its lowest in in the March 2020 quarter at -24.67.

Century Therapeutics, Inc. (IPSC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Century Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Century Therapeutics, Inc. (IPSC) Average PE Ratio

How has IPSC PE Ratio performed in the past?

The current PE Ratio of Century Therapeutics, Inc. (IPSC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Century Therapeutics, Inc. (IPSC) PE Ratio vs. Peers

How is IPSC’s PE Ratio compared to its peers?

Century Therapeutics, Inc.’s PE Ratio is greater than Edgewise Therapeutics, Inc. (-15.70), greater than C4 Therapeutics, Inc. (-3.53), greater than Mineralys Therapeutics, Inc. (-6.65), greater than Cullinan Oncology, Inc. (-6.55), less than Passage Bio, Inc. (-0.61), less than Homology Medicines, Inc. (-0.01), greater than Generation Bio Co. (-1.38), greater than Stoke Therapeutics, Inc. (-6.76), greater than Erasca, Inc. (-3.91), less than NGM Biopharmaceuticals, Inc. (-0.91), greater than Keros Therapeutics, Inc. (-9.61), greater than Monte Rosa Therapeutics, Inc. (-2.08), less than Kezar Life Sciences, Inc. (-0.48), greater than Nkarta, Inc. (-3.07), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than aTyr Pharma, Inc. (-2.33), greater than Relay Therapeutics, Inc. (-3.55), greater than Blueprint Medicines Corporation (-23.96),

Build a custom stock screener for Century Therapeutics, Inc. (IPSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Century Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Century Therapeutics, Inc. (IPSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Century Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.